Javascript must be enabled to continue!
Phenazines Modulate Gastrointestinal Metabolism and Microbiota
View through CrossRef
Abstract
Background: Natural and synthetic phenazines are ubiquitously occurred in environment and have been used for various therapeutic purposes in human, animals and agriculture, and the widespread use makes residue problem in environment and foods increasingly serious. However, the metabolic and comprehensive impacts of phenazines on the digestive tract are poorly understood, particularly the microbial pyocyanin (PYO), the most representative phenazines produced by Pseudomonas . Here, we utilized PYO as the representative of phenazines to study the effects on digestive tract. Results: Metabolic kinetic analysis showed that PYO exhibited low oral bioavailability in both rats and swine model, revealing a restriction of PYO in gut and might cause impacts on digestive tract. PYO was subsequently found to induce intestinal barrier destruction including inflammation and reactive oxygen species (ROS) accumulation in duodenum. Microbiome analysis showed that PYO caused gut microbiota dysbiosis by decreasing the symbiotic bacteria and increasing the opportunistic pathogenic bacteria. Additionally, the integral and dysfunctional assessment of liver demonstrated that PYO induced liver inflammation and metabolic disorder. Metabolism analysis further confirmed that PYO could be metabolized by both gut microbiota and liver, and all metabolites retained the nitrogen-containing tricyclic structural skeleton of phenazines, which was the core bioactivity of phenazine compounds, indicating all the outcomes were due to the intrinsic characteristic of phenazine structure. Conclusions: PYO were low oral bioavailable and all the metabolites retained the nitrogen-containing tricyclic structural skeleton, final resulting in the damages to digestive tract including intestinal barrier destruction, gut microbiota dysbiosis, liver damages and metabolic disorder. These findings elucidated the effect of phenazines on digestive tract in vivo and shed light on the rational design of phenazines for the development and application of such compounds in future.
Title: Phenazines Modulate Gastrointestinal Metabolism and Microbiota
Description:
Abstract
Background: Natural and synthetic phenazines are ubiquitously occurred in environment and have been used for various therapeutic purposes in human, animals and agriculture, and the widespread use makes residue problem in environment and foods increasingly serious.
However, the metabolic and comprehensive impacts of phenazines on the digestive tract are poorly understood, particularly the microbial pyocyanin (PYO), the most representative phenazines produced by Pseudomonas .
Here, we utilized PYO as the representative of phenazines to study the effects on digestive tract.
Results: Metabolic kinetic analysis showed that PYO exhibited low oral bioavailability in both rats and swine model, revealing a restriction of PYO in gut and might cause impacts on digestive tract.
PYO was subsequently found to induce intestinal barrier destruction including inflammation and reactive oxygen species (ROS) accumulation in duodenum.
Microbiome analysis showed that PYO caused gut microbiota dysbiosis by decreasing the symbiotic bacteria and increasing the opportunistic pathogenic bacteria.
Additionally, the integral and dysfunctional assessment of liver demonstrated that PYO induced liver inflammation and metabolic disorder.
Metabolism analysis further confirmed that PYO could be metabolized by both gut microbiota and liver, and all metabolites retained the nitrogen-containing tricyclic structural skeleton of phenazines, which was the core bioactivity of phenazine compounds, indicating all the outcomes were due to the intrinsic characteristic of phenazine structure.
Conclusions: PYO were low oral bioavailable and all the metabolites retained the nitrogen-containing tricyclic structural skeleton, final resulting in the damages to digestive tract including intestinal barrier destruction, gut microbiota dysbiosis, liver damages and metabolic disorder.
These findings elucidated the effect of phenazines on digestive tract in vivo and shed light on the rational design of phenazines for the development and application of such compounds in future.
Related Results
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
The gut microbiota, made up of trillions of microorganisms that inhabit the gastrointestinal tract, plays a fundamental role in human health, influencing immunological and metaboli...
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The work presented is a comprehensive review of the role of the human microbiota in the context of the COVID-19 pandemic. A diverse microbial community heavily colonizes the human ...
Vaginal microbiota and preterm birth
Vaginal microbiota and preterm birth
Vaginal microbiota composition is associated with spontaneous preterm birth (sPTB), depending on ethnicity. Host-microbiota interactions are thought to play an important underlying...
Role of phenazine‐enzyme physiology for current generation in a bioelectrochemical system
Role of phenazine‐enzyme physiology for current generation in a bioelectrochemical system
Summary
Pseudomonas aeruginosa
produces phenazine‐1‐carboxylic acid (PCA) and pyocyanin (PYO), which aid its anaerobic su...
Monitoring oral microbiota-virus associations as biomarkers of immune resistance
Monitoring oral microbiota-virus associations as biomarkers of immune resistance
Relevance. The oral microbiota, including its interactions with viruses, plays a crucial role in an individual's immune system. Investigating these microbiota-virus associations as...
Intestinal microbiota of whitefish (
Coregonus
sp.) species pairs and their hybrids in natural and controlled environment
Intestinal microbiota of whitefish (
Coregonus
sp.) species pairs and their hybrids in natural and controlled environment
Abstract
It is becoming increasingly clear that wild animals have never existed without symbiotic interactions with microbiota. Therefore, invest...
The Impact of Gut Microbiota in the Development and Management of Diabetes
The Impact of Gut Microbiota in the Development and Management of Diabetes
Abstract
The gut microbiota plays a pivotal role in maintaining human health, influencing metabolic processes and immune responses. Emerging evidence suggests that gut mi...
Associations and recovery dynamics of the nasopharyngeal microbiota during influenza-like illness in the aging population
Associations and recovery dynamics of the nasopharyngeal microbiota during influenza-like illness in the aging population
Abstract
Background
Older adults are more susceptible to respiratory pathogens, several of which have been associated with an a...

